Viewing Study NCT06945458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2026-01-31 @ 5:38 PM
Study NCT ID: NCT06945458
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-06
First Post: 2025-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)
Sponsor: Kymera Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None KT621 View
None STAT6 View
None STAT6 degrader View
None Targeted protein degrader View
None Phase 1 View